Mantecorp Industria Quimica e Farmaceutica Ltd.
Quick facts
Marketed products
Phase 3 pipeline
- Dexchlorpheniramine 1% gel · Dermatology / Allergy
Dexchlorpheniramine is a selective H1-receptor antagonist that blocks histamine-mediated allergic and inflammatory responses in topical form. - Dexchlorpheniramine 1% lotion · Dermatology / Allergy
Dexchlorpheniramine is a first-generation H1-receptor antagonist that blocks histamine binding to reduce allergic and inflammatory responses in the skin. - Dexchlorpheniramine, pseudoephedrine, guaifenesin · Respiratory/Allergy
This combination drug reduces allergy symptoms via antihistamine action, nasal congestion via sympathomimetic decongestant, and cough via expectorant action. - Glucosamine sulfate + chondroitin sulfate - CONDROFLEX · Rheumatology/Orthopedics
Glucosamine sulfate and chondroitin sulfate work together to provide substrate for cartilage synthesis and reduce cartilage degradation in osteoarthritis. - Glucosamine sulfate + chondroitin sulfate - MANTECORP · Rheumatology / Orthopedics
Glucosamine sulfate and chondroitin sulfate work together to provide substrates for cartilage matrix synthesis and reduce cartilage degradation in osteoarthritis. - Ibuprofen plus caffeine · Pain Management
Ibuprofen inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis and inflammation, while caffeine enhances analgesic efficacy and reduces drowsiness.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Mantecorp Industria Quimica e Farmaceutica Ltd. portfolio CI brief
- Mantecorp Industria Quimica e Farmaceutica Ltd. pipeline updates RSS
Frequently asked questions about Mantecorp Industria Quimica e Farmaceutica Ltd.
What are Mantecorp Industria Quimica e Farmaceutica Ltd.'s marketed drugs?
Top marketed products include ibuprofen, dipyrone, acetaminophen.
What is Mantecorp Industria Quimica e Farmaceutica Ltd.'s pipeline?
Mantecorp Industria Quimica e Farmaceutica Ltd. has 6 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Dexchlorpheniramine 1% gel, Dexchlorpheniramine 1% lotion, Dexchlorpheniramine, pseudoephedrine, guaifenesin, Glucosamine sulfate + chondroitin sulfate - CONDROFLEX.